Chembio Historical Income Statement

CEMI
 Stock
  

USD 0.88  0.02  2.22%   

Historical analysis of Chembio Diagnostics income statement accounts such as Cost of Revenue of 28.6 M, Gross Profit of 13.3 M or Interest Expense of 3.1 M can show how well Chembio Diagnostics performed in making a profits. Evaluating Chembio Diagnostics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Chembio Diagnostics's future profits or losses. Financial Statement Analysis is much more than just reviewing and examining Chembio Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Chembio Diagnostics is a good buy for the upcoming year.
Continue to Trending Equities.
  

About Chembio Income Statement Analysis

Chembio Diagnostics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Chembio Diagnostics shareholders. The income statement also shows Chembio investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Chembio Diagnostics Income Statement Chart

Chembio Diagnostics Income Statement is one of the three primary financial statements used for reporting Chembio's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Chembio Diagnostics revenue and expense. Chembio Diagnostics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Chembio Diagnostics Operating Expenses is most likely to increase significantly in the upcoming years. The last year's value of Operating Expenses was reported at 44.38 Million. The current Selling General and Administrative Expense is estimated to increase to about 26.8 M, while Consolidated Income is projected to decrease to (34.8 M).

Consolidated Income

The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of Net Income Available to Non-controlling Interests.

Earning Before Interest and Taxes EBIT

Earnings Before Interest and Tax is calculated by adding Income Tax Expense and Interest Expense back to Net Income.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Chembio Diagnostics financial statement analysis. It represents the amount of money remaining after all of Chembio Diagnostics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Revenues

Revenues refers to the total amount of money received by Chembio Diagnostics for goods sold or services provided during a certain time period. It also includes all of Chembio Diagnostics sales as well as any other increase in Chembio Diagnostics equity.Revenues are reported on Chembio Diagnostics income statement and calculated before any expenses are subtracted. Amount of Revenue recognized from goods sold; services rendered; insurance premiums; or other activities that constitute an earning process. Interest income for financial institutions is reported net of interest expense and provision for credit losses.
Most accounts from Chembio Diagnostics income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Chembio Diagnostics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Trending Equities.Chembio Diagnostics Operating Expenses is most likely to increase significantly in the upcoming years. The last year's value of Operating Expenses was reported at 44.38 Million. The current Selling General and Administrative Expense is estimated to increase to about 26.8 M, while Consolidated Income is projected to decrease to (34.8 M).
 2019 2020 2021 2022 (projected)
Revenues USD34.46 M32.47 M47.82 M41.89 M
Revenues34.46 M32.47 M47.82 M41.89 M

Chembio Diagnostics income statement Correlations

Chembio Diagnostics Account Relationship Matchups

Chembio Diagnostics income statement Accounts

201720182019202020212022 (projected)
Direct Expenses12.92 M21.43 M22.39 M23.87 M34.5 M37.22 M
Consolidated Income(6.37 M)(7.87 M)(13.68 M)(25.52 M)(33.9 M)(34.8 M)
Cost of Revenue12.92 M22.6 M22.39 M23.87 M34.5 M28.6 M
Earning Before Interest and Taxes EBIT(6.46 M)(7.98 M)(13.33 M)(23.14 M)(31.05 M)(31.87 M)
Earning Before Interest and Taxes USD(6.46 M)(7.98 M)(13.33 M)(23.14 M)(31.05 M)(31.87 M)
Gross Profit11.09 M11.98 M12.07 M8.6 M13.32 M13.29 M
Net Income(6.37 M)(7.87 M)(13.68 M)(25.52 M)(33.9 M)(34.8 M)
Net Income Common Stock(6.37 M)(7.87 M)(13.68 M)(25.52 M)(33.9 M)(34.8 M)
Net Income Common Stock USD(6.37 M)(7.87 M)(13.68 M)(25.52 M)(33.9 M)(34.8 M)
Operating Expenses17.58 M19.96 M25.4 M31.73 M44.38 M47.88 M
Operating Income(6.48 M)(7.98 M)(13.33 M)(23.14 M)(31.05 M)(31.87 M)
Revenues24.02 M34.58 M34.46 M32.47 M47.82 M41.89 M
Revenues USD24.02 M34.58 M34.46 M32.47 M47.82 M41.89 M
Research and Development Expense8.56 M8.53 M8.54 M9.51 M12.49 M10.91 M
Selling General and Administrative Expense8.96 M11.1 M16.14 M21.04 M24.84 M26.8 M
Weighted Average Shares12.3 M14.43 M16.95 M19.09 M24.3 M20.25 M
Weighted Average Shares Diluted12.3 M14.43 M16.95 M19.09 M24.3 M20.34 M
Income Tax Expense(88.31 K)(67.52 K)(500.29 K)(456.79 K)(62.05 K)(66.95 K)

Chembio Diagnostics Investors Sentiment

The influence of Chembio Diagnostics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chembio. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Chembio Diagnostics Implied Volatility

    
  397.54  
Chembio Diagnostics' implied volatility exposes the market's sentiment of Chembio Diagnostics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Chembio Diagnostics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Chembio Diagnostics stock will not fluctuate a lot when Chembio Diagnostics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Chembio Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Chembio Diagnostics' short interest history, or implied volatility extrapolated from Chembio Diagnostics options trading.

Pair Trading with Chembio Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chembio Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chembio Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Chembio Diagnostics

0.68AWHAspira Womans Health Earnings Call  TodayPairCorr
0.7AXDXAccelerate Diagnosti Earnings Call  This WeekPairCorr

Moving against Chembio Diagnostics

0.64AIMAim Immunotech Earnings Call  TodayPairCorr
0.61ABCAmerisourcebergen Corp Fiscal Year End 3rd of November 2022 PairCorr
0.6AGRXAgile Therapeutics Earnings Call  TomorrowPairCorr
0.57ABVCAbvc Biopharma Earnings Call  TomorrowPairCorr
The ability to find closely correlated positions to Chembio Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chembio Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chembio Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chembio Diagnostics to buy it.
The correlation of Chembio Diagnostics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chembio Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chembio Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chembio Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
31.1 M
Quarterly Revenue Growth YOY
0.42
Return On Assets
-0.3
Return On Equity
-2.06
The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.